Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Berberine and Reduced Body Weight

Research synthesisLow evidenceModerate effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects of berberine on body weight, with 1 neutral finding. The predominant effect size was moderate, though effect sizes ranged from small to moderate. Evidence comes primarily from clinical populations with metabolic conditions (MASLD, obesity, type 2 diabetes). Median study duration was 87 days (~12 weeks), suggesting effects typically observed at 8–12 weeks. The most commonly tested dose (where reported) was 1200 mg/day.

  • Effective dose range: 1200 mg/day (reported in only 1 study; others did not specify dose)
  • Studied populations: adults with MASLD, adults with obesity, patients with type 2 diabetes

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. One neutral RCT from 2025 in type 2 diabetes patients found no significant effect on anthropometric parameters, introducing some inconsistency.

Generated Jun 15, 2026
Doses used in studies
  • mg/day: 1,200 (median 1,200, IQR 1,2001,200) 1 study
Time to effect
Median: 2.9 months · IQR 2.9 months3 months · Range 2.8 months3 months — Reported in 2 of 4 studies
Safety in these studies
4 of 4 papers
Back to top